Is Trimi's compounded tirzepatide FDA-approved
Alcohol Use Disorder Outcomes A national cohort study in Denmark of 38,454 individuals showed that GLP-1 medications were associated with a reduced risk of alcohol-related outcomes after three months of treatment, which included fewer hospitalizations, registered alcohol use disorder treatment, and purchase of medications to manage alcohol withdrawal (Wium-Andersen et al., 2022)
Sulfur burps on Ozempic (semaglutide 0.5-2 mg): Incidence, Severity, and Realistic Expectations Sulfur burps on Ozempic (semaglutide 0.5-2 mg): Incidence, Severity, and Realistic Expectations At a glance Reported incidence (trial data): Eructation reported in approximately 6-8% of participants at the 1 mg dose and up to ~7% at 2 mg in the SUSTAIN trial program
Strength Training: Focus on exercises that build and maintain muscle mass
Five types of ceramides (EOP, NG, NP, AG, AP) for barrier support and hydration